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Abstract
Influenza virus infection induces a potent initial innate immune response, which serves to limit the 
extent of viral replication and virus spread. However, efficient (and eventual) viral clearance 
within the respiratory tract requires the subsequent activation, rapid proliferation, recruitment, and 
expression of effector activities by the adaptive immune system, consisting of antibody producing 
B cells and influenza-specific T lymphocytes with diverse functions. The ensuing effector 
activities of these T lymphocytes ultimately determine (along with antibodies) the capacity of the 
host to eliminate the viruses and the extent of tissue damage. In this review, we describe this 
effector T cell response to influenza virus infection. Based on information largely obtained in 
experimental settings (i.e., murine models), we will illustrate the factors regulating the induction 
of adaptive immune T cell responses to influenza, the effector activities displayed by these 
activated T cells, the mechanisms underlying the expression of these effector mechanisms, and the 
control of the activation/differentiation of these T cells, in situ, in the infected lungs.
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1 Introduction
In this section of the volume of Current Topics in Microbiology and Immunology on 
Influenza Pathogenesis and Control, we focus on the contribution of a specific subset of 
adaptive immune cells, that is activated T effector cells, to the control of viral replication in 
the host response to influenza A virus (IAV) infection. These activated T effector cells are 
classically categorized as CD8+ cytotoxic T lymphocytes (CTLs) and CD4+ T helper (TH) 
cells. However, there is evidence for considerable heterogeneity of function among these T 
lymphocytes subsets, most notably among the TH cells.
Both T cell subsets have been reported to have regulatory or suppressive activity against 
other adaptive or innate immune cell types. The most prominent cell type identified with 
such regulatory activity is the CD4+ T regulatory cell subset which can be directed to either 
self-constituents and/or foreign molecules such as the IAV gene products. Another 
important but only more recently appreciated distinct subset of CD4+ T cells is the subset of 
T cells which regulate B cell activation and germinal center formation in response to 
infection, the so-called T follicular helper T cell subset.
In this review, we will exclude the CD4+ (and CD8+) T regulatory cells as well as the T 
follicular helper T cell subset and restrict our focus to “conventional” CTLs and TH cells 
which exhibit the capacity to migrate from draining lymph nodes (DLNs) to the site of IAV 
infection in the lungs. We will systematically review the factors regulating the induction of 
the effector cells from naïve precursors (and the role of respiratory dendritic cells in this 
process), expression of effector activities by these activated T cells, and the regulation of the 
activation and differentiation state of these T effector cells in the IAV-infected lungs.
2 Initiation of Adaptive Immunity
2.1 Dendritic Cell Networking in the Steady-State and Inflamed Lung
Because of its continuous encounter with the environment as it carries out its essential role 
in gas exchange, the respiratory tract is exposed to airborne foreign particles, such as 
pollutants, allergens, dusts, and microorganisms. The lungs have therefore evolved a variety 
of strategies to sense, respond to, and cope with these potential ‘dangers,’ including the 
establishment of a well-developed network of dendritic cells (DCs). DCs serve as the 
sentinels of the immune system at body surfaces (e.g., the lungs, skin, and gut), linking the 
response of innate immune cells and molecular sensors to the induction of adaptive 
immunity (Banchereau and Steinman 1998). DCs were once thought to be a homogenous 
population that was difficult to distinguish phenotypically from lung-resident alveolar 
macrophages. However, recent advances in the development of genetic tools to provide 
definitive information on DC biology now make it clear that DCs are a heterogenous cell 
population consisting of distinct DC subsets with discrete functions and with developmental 
pathways separate from the macrophage lineages (Helft et al. 2010). In the lung, DCs 
perform a range of tasks including recognition and acquisition of antigens derived from 
pathogens and allergens, antigen transportation to the regional lymph nodes, and perhaps 
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most importantly, induction of CD4+ or CD8+ T cell immunity (Braciale et al. 2012; 
Lambrecht and Hammad 2012).
In the unperturbed lung, the DC network is composed of several distinct respiratory DC 
(RDC) subsets that differ in phenotype, anatomic localization, and function (Table 1). Of 
these, CD103+ and CD11bhi RDC subsets exhibit several features characteristics of DC 
found in extralymphoid mucosal sites and are distributed at distinct anatomical sites: 
primarily intraepithelial localization for CD103+ RDC and submucosal/interstitial 
distribution for CD11bhi RDC (Sung et al. 2006; del Rio et al. 2007; Edelson et al. 2010). In 
addition to these major populations, monocyte-like RDC (Mo-RDC) are also readily 
detectable in the uninflamed lung (Hao et al. 2008; Kim and Braciale 2009). In certain 
microenvironments within the lung parenchyma (i.e., alveolar septa), so-called conventional 
RDC (cRDC) (e.g., CD103+ and CD11bhi RDC) and plasmacytoid DC (pDC) are both 
detectable. The human counterparts of murine CD103+, CD11bhi RDC and pDC have 
recently been identified in the human lung (Table 1) (Villadangos and Shortman 2010; Neyt 
and Lambrecht 2013). Thus, several distinct DC subsets strategically positioned at the 
interface between the lung and the surroundings sense and sample the respiratory tract.
The aforementioned DC subsets are largely identifiable in inflammatory conditions such as 
viral infections; however, inflammatory mononuclear cells recruited to and infiltrating the 
inflamed tissues in response to infection (e.g., monocytes) add to the complexity of DC 
network in the infected lungs since many of them express/upregulate prototypical DC 
markers such as CD11c, major histocompatiblity complex (MHC) II and costimulatory 
markers at various levels (Lin et al. 2008). The potential precursor-product relationship 
between CD11bhi DCs and Mo-RDC in steady-state as well as inflamed lung remains at 
present speculative. A DC subset prominent in IAV-infected lung, but minimal in the normal 
lung, is TNF+iNOS+ DC (TipDC) (Aldridge et al. 2009). These DC are likely derived from 
the circulating Ly6C+CCR2+ monocyte subset that are rapidly mobilized to the infected lung 
upon viral infection and contribute to both the viral control and immunopathology.
2.2 Activation of DCs and Antiviral Innate Immunity in the Lung
Prompt activation of innate antiviral immunity at the site of virus replication is a crucial step 
toward ultimate control of pathogen replication and a successful host defense against 
invading pathogens such as IAV. In particular, DC activation is pivotal to initiate adaptive 
immunity and to ultimately clear infectious virions from the infected lung (Braciale et al. 
2012; Neyt and Lambrecht 2013). The recent discovery of several DC subsets in the lung 
implies that these distinct RDC subsets likely respond differently (i.e., display distinctive as 
well as overlapping functions) to a given virus; however, most studies investigating 
respiratory virus infection have not yet fully assimilated the impact of this DC heterogeneity 
into the cellular/molecular processes underpinning the induction and expression of the host 
response: an area meriting further detailed investigation.
Resting DCs in the lung can be stimulated by several mechanisms upon IAV infection. 
Foremost, DCs are equipped with a various innate immune recognition receptors that 
recognize conserved pathogen-associated molecular patterns (PAMPs). Specific pattern 
recognition receptors (PRRs) for these PAMPs include Toll-like receptors (TLRs), retinoic 
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acid-inducible gene-1 (RIG-1)-like receptors (RLRs), and NOD-like receptors (NLRs). 
Several forms of IAV nucleic acids can be recognized by TLR3 (dsRNA) and TLR7/8 
(ssRNA) (Yoo et al. 2013). Within the DC compartments, gene array data compiled in the 
Immunological Genome Project reveal that CD103+ RDCs predominately express TLR3, 
whereas CD11bhi RDCs express TLR2/7. Although the contribution of PRR recognition of 
viral PAMPs has been well-established in vitro, the relevance of PAMP/PRR interaction to 
the development of innate and adaptive immunity in vivo after IAV infection is less clear. 
Neither the absence of TLR3 (Le Goffic et al. 2006) or the RIG-I signaling adaptor 
mitochondrial antiviral signaling (MAVS) (Koyama et al. 2007) diminishes virus clearance 
and the adaptive immunity to IAV infection. Furthermore, Tlr7−/− or Tlr7-/-Mavs-/- mice are 
able to mount an effective CTL response and efficiently clear IAV (Heer et al. 2007; Pang et 
al. 2013a). Paradoxically, TLR7 and RIG-1 signals are required for efficient IAV replication 
in vivo (Pang et al. 2013b). These studies suggest a considerable complexity among 
different PAMPs/PRRs (and the cell types in the lung expressing these PRRs) in their ability 
to support the induction of antiviral immunity.
Although direct recognition of viral nucleic acids and proteins by PRRs is the primary 
stimulatory pathway, DC activation through the recognition of nonmicrobial danger signals 
associated with cellular stress or damage as a result of infection has also been increasingly 
recognized. Damage-associated molecular patterns (DAMPs) are the host cell constituents 
released from damaged/dying cells as well as intact cells located within sites of viral 
replication. Notable DAMPs include nucleotides, heat shock proteins, nuclear proteins (e.g., 
HMGB1), mitochondrial DNA, cytokines, and reactive oxygen species (Said-Sadier and 
Ojcius 2012). Virus propagation within the respiratory tract results in the leak of or 
stimulates the release of DAMPs from intracellular compartments as well as extracellular 
sources (e.g., extracellular ATP, extracellular matrix components, and uric acids) (Pang and 
Iwasaki 2011). These DAMPs (also known as ‘alarmins’ or ‘danger signals’) serve to alert 
the host immune system and along with viral PAMPs, are believed to play a crucial role in 
activating innate immune sentinels such as DC in the airway mucosa in part via an 
inflammasome-dependent mechanism.
Inflammasomes are large intracellular multiprotein complexes consisting of NLR family 
members, such as NLRP3 and IPAF. The DAMP-activated NLR protein complex recruits 
the inflammasome-adaptor protein ASC, which in turn engages caspase-1 leading to 
caspase-1 activation. Once activated, caspase-1 promotes the maturation of the pro-
inflammatory cytokines interleukin (IL)-1β and IL-18 (Said-Sadier and Ojcius 2012). By 
virtue of their ability to detect and respond to a large range of PAMPs and DAMPs, 
inflammasomes are an integral part of the host defense to pathogens like IAV. Indeed, IAV-
derived ssRNA can, in an NLPR3-dependent manner, activate the inflammasome complex 
in a variety of cell types including bone marrow-derived DCs or macrophages (Kanneganti 
et al. 2006). In addition, the IAV-M2 viral protein, a proton-selective ion channel, can serve 
as an ionophore to promote nucleotide transport into the cell cytosol and directly trigger 
caspase-1 activation and secretion of IL-1β (Ichinohe et al. 2009). The importance of 
inflammasome activation to anti-IAV immunity is evident in mice deficient in 
inflammasome complex-associated molecules, such as NLPR3, IL-1R, caspase-1, or ASC. 
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These mice exhibit sustained, elevated lung viral titers, reduced infiltration of neutrophils 
and monocytes into the infected lung, an impaired adaptive immune response, and reduced 
cytokine/chemokine levels compared to infected inflammasome-sufficient mice (Ichinohe et 
al. 2009; Thomas et al. 2009; Allen et al. 2011). Although reports differ in the extent to 
which inflammasome impairment affects the host response to respiratory virus infection, the 
accumulating data overall strongly suggest that activation of the NLRP3-dependent 
inflammasome and the ensuing activation of the IL-1/IL-1R-mediated signaling defense are 
critical for the establishment of antiviral innate and adaptive immunity (Pang et al. 2013a). It 
is likely that additional DAMPs will be identified which are involved in modulating lung 
DC activation and antiviral immunity during IAV infection.
2.3 Antigen Acquisition and Migration of Lung DCs
After activation in the lung, RDCs carry out two distinct roles in the host response to IAV 
infection. On one hand, perhaps the most important and unique function of RDC in the 
infected lung is the capture of antigen derived from IAV for delivery to the DLN. Upon 
arrival here, the migrant RDCs present the processed viral peptides to IAV-specific T cells 
to initiate adaptive immunity. On the other hand, the activated DCs release various pro-
inflammatory mediators in the infected lung which serve to limit viral replication and spread 
but when released in excess, enhance disease severity.
The acquisition of IAV antigen in the lung by cRDC prior to their egress from the inflamed 
lung is most likely achieved by direct infection of RDC. Different DC subsets in both mice 
and humans differ in susceptibility to IAV infection. In case of IAV H1N1 PR/8 infection in 
mice, CD103+ RDCs, unlike CD11bhi RDCs, are highly susceptible to infection with this 
strain in vivo (Hao et al. 2008; Manicassamy et al. 2010; Hargadon et al. 2011). This 
differential susceptibility among the RDC subsets to IAV infection is in part dependent on 
DC-intrinsic sensitivity to type 1 interferons (IFN) (Moltedo et al. 2011). DC infection by 
human IAV fails to release infectious virions likely due to lack of hemagglutinin cleavage 
by furan enzymes. Furthermore, phagocytic engulfment of cell-free virions or dying/dead 
infected cells harboring viral antigen (e.g., respiratory epithelial cells and neutrophils) is 
another feasible mechanism. In addition, antigen acquisition by a membrane nibbling 
process, known as ‘trogocytosis’ (Desch et al. 2011), can be employed by activated DCs, 
although this latter remains to be formally demonstrated during IAV infection. Viral antigen 
transfer from migrant antigen-bearing RDC to LN-resident DC (i.e., CD8α+ DC) for 
presentation to naïve T cells (i.e., cross-presentation) has also been reported (Belz et al. 
2004). The relative contribution of these various mechanisms of antigen uptake and their 
impact on antigen presentation efficiency and the subsequent antiviral immune response is 
currently ill-defined.
Following an inflammatory stimulus like virus infection (see below), the viral antigen-
bearing activated RDC migrate to the DLN along a chemokine gradient dependent on 
expression of the chemokine receptor CCR7 (Kim and Braciale 2009). Although the detailed 
molecular mechanisms underlying CCR7 upregulation by RDC after IAV infection remains 
elusive, stimulation through receptors for PAMPs and DAMPs likely play an integral role in 
promoting DC migration. Stimulation by DAMPs and inflammasome activation can recruit 
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immature DCs and induce their functional maturation, leading them to take up antigens and 
home to secondary lymphoid organs. After IAV infection of mice deficient in IL-1R 
signaling, the migration of CD103+ RDC to the DLN is severely impaired, along with a 
reduction in the total accumulation of inflammatory/immune cells into the DLN and the 
subsequent impairment of the antiviral CTL and TH cell responses in the infected lungs (see 
below). On the other hand, it is noteworthy that persistent or unchecked release of DAMPs 
(i.e., S100A9) into the local milieu can lead to excessive stimulation of innate immune cells 
including DCs (Tsai et al. 2014), which can trigger aberrant uncontrolled T cell proliferation 
(perhaps even self-reactive T cells). Thus, net effects of DAMPs to host immunity are 
determined by the microenvironment and DAMP concentration.
The complement system is an essential component of innate immunity and bridges between 
the innate and adaptive immune systems. Similar to viral PAMPs and cellular DAMPs, 
components of the complement pathway in the lung provide additional immunological cues 
to DC activation and antiviral immunity to IAV infection. Complements, however, affect 
DC migration rather than the DC’s T cell stimulatory activity (Kandasamy et al. 2013). Mice 
deficient in complement following IAV infection resulted in diminished lung DC migration 
(notable in CD103+ RDC compartment) and accumulation into the DLN, contributing to the 
subsequent impaired anti-IAV T cell response in the infected lungs. Of interest, CD103+ 
RDC possesses a unique capacity to both sense and produce complement, thereby 
controlling both its own migration and the migration of CD11b+ RDCs from the infected 
lung into the MLN.
2.4 Antigen Presentation and T Cell Activation in the DLNs
Efficient viral clearance from the site of infection and establishment of lifelong protective 
immunity against intracellular pathogens such as viruses requires the activation of CTLs and 
TH cells. Naive T cells undergo several distinct phases of immune responses including 
clonal expansion, acquisition of effector function, migration to the site of infection, and self-
renewal (Williams and Bevan 2007). Initial programming of T lymphocyte responses occurs 
sequentially in lymphoid tissues draining sites of infection where IAV-specific naïve T cells 
are selected by professional antigen presenting cells (APCs) to proliferate, yielding 
functionally distinct activated T cell subsets with different functions and fates (Lawrence 
and Braciale 2004; Yoon et al. 2010).
Among the DC populations present in the DLN of IAV infected mice (i.e., migrant CD103+, 
CD11bhi and Mo-DC, pDC, CD8α+/− LNDC), the lung-derived migrant CD103+ and 
CD11bhi RDCs serve as the primary APCs for naïve IAV-specific T cells albeit with 
different capacities (Kim and Braciale 2009). CD103+ migrant RDCs are the most potent 
APC for activating CTLs following IAV infection among the DC subsets in the DLN. 
CD103+ RDCs (but not CD11bhi RDCs) also have the capacity to capture noninfectious 
virus preparations delivered into the RT, then process and present IAV antigens CTLs (i.e., 
cross-presentation) (Kim and Braciale 2009; Helft et al. 2012). In keeping with its prominent 
role in priming antiviral CTLs, selective depletion of langerin-expressing CD103+ RDCs 
prior to IAV infection (GeurtsvanKessel et al. 2008) or mice constitutively lacking CD103+ 
RDCs (Batf3-deficient mice) (Helft et al. 2012) results in a severely diminished CTL 
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response and impaired virus clearance from the lungs with subsequent infection. While the 
mechanistic basis for the potency displayed by CD103+ RDC to prime CTL activation are 
under intense instigation, its superior cross-presenting ability (Kim and Braciale 2009; 
Moltedo et al. 2011; Helft et al. 2012) along with enhanced loading of processed antigen 
onto MHC I molecules (Ho et al. 2011) have been described. In support of this view, 
CD103+ DCs (and CD8α+ DC) preferentially express the DC receptor DNGR-1 (CLEC9A), 
which is implicated in cross-priming (Schreibelt et al. 2012; Zelenay et al. 2012).
Consistent with its dominant role in CTL priming, CD103+ RDC migration and 
accumulation in the DLN is rigorous at an earlier phase (i.e., up to day 4 post-infection in 
mice) (Kim and Braciale 2009). Following this initial wave of migration and antigen 
presentation to CTLs by CD103+ RDC, IAV antigen is continuously replenished and 
presented to T cells in the DLN by migrant CD11bhi RDCs. This temporal transition of APC 
to CD11bhi RDC in a greater quantity at later phases could serve as an amplification loop for 
generating CTLs until the resolution of the acute infection (Ballesteros-Tato et al. 2012). In 
contrast to migrant cRDC subsets, pDC has been reported to capture viral antigen in the 
lung, but antigen positive pDCs in the DLN fail to induce CTL responses during sublethal 
IAV infection (GeurtsvanKessel et al. 2008; Wolf et al. 2009). However, pDCs appear to 
play a role in eliminating virus-specific CTLs in the infected lung via Fas/Fas ligand (FasL) 
interaction and enhance mortality during lethal infection (Langlois and Legge 2011). 
Likewise, antigen-bearing Mo-RDC are detected in the DLN; however, they exhibit a 
minimal, if any, activity to stimulate CTL proliferation (Kim and Braciale 2009).
In contrast to their differing ability to activate naïve IAV-specific CD8+ T cells, migrant 
CD103+ and CD11bhi RDC subsets both robustly trigger naive CD4+ T cell activation with 
an equal efficiency (Nakano et al. 2009). In addition, other DC subsets such as Mo-RDC can 
drive CD4+ T cell differentiation into TH1 cells, albeit with lower efficiency (Nakano et al. 
2009). Thus, lung DC subsets accumulated in the DLN display a differential hierarchy in 
APC function for the activation of anti-IAV CTL and TH cells. The distribution of distinct 
activities among DC subsets in the regulation of the host immune response and IAV 
pathogenesis is poorly characterized and is of great interest in discovering novel therapeutics 
and vaccinations.
3 Lymphocyte Migration into the IAV-Infected Lung
T lymphocyte migration into the lung has relatively defined, albeit overlapping, steps: 
selectin interactions between lymphocytes and the vascular endothelium mediate rolling and 
tethering stages; firm lymphocyte adhesion onto the lung vascular network is mediated by 
integrin interactions; and coordinated migration into the respiratory tract is regulated by 
integrins and chemokine gradients.
IAV-specific lymphocyte migration into nonlymphoid tissues has both specific and 
nonspecific components (Masopust and Schenkel 2013). The integrin CD11a, which is only 
upregulated in activated T cells, is required for optimal lung vascular adhesion and retention 
within the respiratory tract allowing preferential recruitment over naïve cells (Thatte et al. 
2003). In addition, RDCs preferentially upregulate the chemokine receptor CCR4 on 
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effector T cells, allowing selected recruitment to the IAV-infected lung, wherein the 
corresponding ligands CCL17 and CCL22 are produced (Mikhak et al. 2013). However, 
ICAM-1, the corresponding ligand for CD11a is constitutively expressed in secondary 
tissues allowing nonspecific recruitment of effector cells (Thatte et al. 2003), and during 
influenza infection, a large number of IAV-specific CTLs are detected in noninflamed 
tissues (Lawrence and Braciale 2004). This dichotomy of nonspecific and specific 
recruitment of activated lymphocytes may allow heightened systemic immunosurveillance 
on one hand while allowing preferentially, but not stringent, enrichment at the site of 
infection on the other.
T cell migration into the airways, the principal site of IAV replication, may occur either 
through T cells transversing the respiratory epithelium from the lung interstitium or direct 
entry from the circulation. The ability of T cells to migrate into the airways is selective, with 
CTL recruitment favored over TH cells due to an unknown mechanism. CTL entry into the 
airways from the circulation is dependent on IL-15 (Verbist et al. 2011), which is regulated 
by type I IFN (Mattei et al. 2001). IL-15 can increase CD11a expression (Allavena et al. 
1997), and IL-15 itself is chemotactic (Verbist et al. 2011). It is currently unclear which 
signals are required to promote migration from the lung interstitium into the airways or 
whether this is a major avenue of migration into the airspace environment.
It is noteworthy that a significant fraction of T lymphocytes (as well as innate immune cells 
(e.g., neutrophils, monocytes)) localized to the normal/unperturbed lungs are not located 
within the pulmonary interstitium but rather remain “marginated” within the circulation of 
the pulmonary vasculature even following lung profusion (Anderson et al. 2012). Therefore 
following infection, the frequency of innate immune and antigen-specific adaptive immune 
cells within the “lungs” will need to take into account cell numbers within the airspaces, 
interstitium, and pulmonary vasculature.
4 Adaptive Immune-Mediated Antiviral Activity in the Lung
The arrival of IAV-specific TH cells (more precisely CD4+ effector T cells) and CD8+ CTLs 
into the respiratory tract coincides with a significant impact on overall virus titer. Adaptive 
immune cells and their products (e.g., immune-modulating cytokines and chemokines, 
neutralizing antibodies, etc.) act in concert, and in a partly redundant fashion, in ultimately 
eliminating infectious virus. In the murine model of IAV infection, efficient viral clearance 
is not solely dependent on TH cells or CTLs (Eichelberger et al. 1991; Topham et al. 1996a; 
Topham and Doherty 1998); however, the removal of both cell types (i.e., via acute 
depletion or genetic deficiency) renders mice incapable of clearing IAV from the respiratory 
tract (Wells et al. 1981; Topham et al. 1997). Thus, the adaptive immune response to 
primary IAV infections implements a multifaceted approach to virus elimination not 
dependent on any one cell type.
The relative contribution of CTLs to optimal IAV clearance has been highlighted with the 
use of β2-M deficient mice (i.e., defective in MHC I display and presentation), which have a 
severe reduction in the number of CTLs. These mice are able to clear IAV in the absence of 
CTLs albeit with a delay in viral clearance depending on viral strain (Eichelberger et al. 
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1991; Bender et al. 1992). More so, infection of β2-M deficient mice with a highly virulent 
strain of influenza results in reduced survival (Bender et al. 1992). These data indicate IAV-
specific CTL effector activity has a significant impact on viral clearance, with the 
requirement for this effector cell type in experimental models, dependent on the virulence of 
the influenza stain. While CTLs produce robust levels of cytokines and chemokines upon 
antigen encounter, the primary contribution of CTLs to IAV clearance is through the 
cytotoxic elimination of IAV-infected respiratory epithelial cells (RECs) (Lukacher et al. 
1984; Hou and Doherty 1995; Topham et al. 1997; Hufford et al. 2011). Due to unhindered 
access to the respiratory epithelium and their concentration in the airways, CTLs localized to 
the airspace are likely the primary mediators of eliminating infected RECs; however, there is 
evidence MHC I is localized basolateral on the respiratory epithelium (Walters et al. 1999), 
and it may be that CTLs eliminate IAV-infected RECs as they transverse the basement 
membrane into the airways.
IAV-specific TH cells are the dominant adaptive immune cell type localized in the lung 
during the time of IAV clearance. TH cells express a wide array of soluble mediators (e.g., 
IFNγ, IL-2, IL-10) (Sun et al. 2009, 2011) and can be cytotoxic (Graham et al. 1994; Brown 
et al. 2006; Hua et al. 2013). Although TH cytotoxic mechanisms may contribute to the 
control of virus replication and elimination (Brown et al. 2006; Hua et al. 2013), TH cell 
anti-IAV roles may be primarily indirect through cytokine production and B cell help 
(Topham et al. 1996a, b; Topham and Doherty 1998).
4.1 T Lymphocyte Cytotoxic Mechanisms
T lymphocytes employ cytotoxic mechanisms to eliminate cells infected with intracellular 
pathogens such as IAV. The exquisite specificity of T cell-mediated killing is dependent on 
the interaction between the T cell receptor (TCR) and requisite antigen complexed with 
MHC on the infected cell. Unlike cytokine production, TCR signaling strength required to 
elicit cytolysis is minimal (Valitutti et al. 1996; Faroudi et al. 2003; Purbhoo et al. 2004), 
and killing is unilateral allowing the T effector cell to survive following target cell 
engagement (Kupfer et al. 1986). This allows a given T lymphocyte to serially eliminate a 
number of virally infected cells in a short manner of time. Despite this rapid killing, T cell-
mediated cytotoxicity exhibits little nonspecific killing. The requirement of specific antigen 
to elicit cytotoxicity and the polarized release of cytolytic material towards the target cell 
with the formation of a tight ring of adhesion molecules around the point of release are all 
thought to limit potential damage in uninfected neighboring cells (Lukacher et al. 1984; 
Dustin and Long 2010).
T lymphocyte-mediated cytotoxicity is mediated by two distinct mechanisms: (1) granule 
exocytosis which utilizes the pore-forming protein, perforin, to facilitate the entry of serine 
proteases and (2) the engagement of tumor necrosis factor (TNF) family members with their 
respective ligands (Fig. 1). Both pathways initiate apoptotic cascades within the target cell 
culminating in target cell death (Russell and Ley 2002). In several murine viral infection 
models, granule exocytosis alone is the principal means of immune-mediated cytotoxic 
clearance (Kagi et al. 1994; Walsh et al. 1994; Mullbacher et al. 1999); however, 
perforindeficient mice have no defect in clearing IAV infection (Topham et al. 1997). Only 
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when RECs lacked the expression of Fas, a TNF family member involved in cell death, and 
T cells were deficient in granule exocytosis (perforin deficiency) were mice unable to 
efficiently clear IAV infection (Topham et al. 1997; Hufford et al. 2011). Therefore, T cells 
employ both granule exocytosis and TNF family member pathways to eliminate IAV-
infected cells. Importantly, these studies also highlight that the elimination of virally 
infected RECs, the cell type propagating infectious IAV, is a critical step in T cell-mediated 
influenza virus clearance.
4.1.1 Granule Exocytosis—Granule exocytosis involves the coordinate release of 
secretory lysosomes upon TCR engagement with cognate antigen/MHC complexes on a 
target cell. These cytotoxic granules contain a variety of serine proteases termed granzymes 
and the pore-forming protein perforin. Upon granule tethering and fusion with the plasma 
membrane, perforin complexes form on the target cell allowing the transfer of pro-apoptotic 
granzmes into the target cell, which rapidly undergoes programmed cell death. Despite the 
presence of perforin pores on the target cell, very little cell lysis (and subsequent release of 
inflammatory DAMPs) has been observed (Lopez et al. 2012), potentially limiting the 
inflammation resulting from granule exocytosis.
A variety of granzymes have been identified in both human and mouse, and their individual 
functions are ill-defined and controversial (Susanto et al. 2012). Granzyme B, which is well 
studied, initiates target cell apoptosis by two distinct mechanisms (Waterhouse et al. 2005; 
Kaiserman et al. 2006; Cullen et al. 2007). In mice, granzyme B preferentially cleaves pro-
caspases directly into their pro-apoptotic active form. Human granzyme B mediated 
apoptosis is largely dependent on cleavage of the BH3 interacting domain death agonist 
(Bid), thereby initiating the mitochondrial apoptotic pathway and caspase activation. Other 
granzymes can also initiate cell death but with distinct mechanisms. For example, granzyme 
K-induced apoptosis is dependent on Bid cleavage but independent of downstream caspase 
activation (Zhao et al. 2007; Guo et al. 2010).
Granzyme activity is not limited to triggering apoptotic cell death. Granzyme K can disrupt 
influenza nucleocapsid protein importation into the nucleus thereby inhibiting virus 
replication in vivo (Zhong et al. 2012). In addition, granzymes have the potential to modify 
the extracellular matrix (Buzza et al. 2005) and trigger target cell cytokine production (e.g., 
TNF, IL-1β) (Metkar et al. 2008; Joeckel et al. 2011); however, it is unclear whether these 
latter functions are pivotal during IAV clearance and subsequent tissue damage.
While individual granzymes have distinct functions, granzyme-mediated cell death is 
dependent on perforin as evidenced by the inability of perforin-deficient mice to exhibit 
granule exocytosis (Kagi et al. 1994). Perforin functions by binding to the target cell 
membrane in a receptor-independent mechanism and forming multimeric complexes 
(Blumenthal et al. 1984; Voskoboinik et al. 2005). The subsequent pore in the target cell 
membrane permits the transfer of the constituents of the cytotoxic granules. It is currently 
unclear whether granzymes passively diffuse through large perforin pores on the target cell 
membrane surface or through a more active process within endocytic membranes (Lopez et 
al. 2012; Susanto et al. 2012). Thus, the precise role of perforin in this process remains to be 
elucidated.
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During IAV infection, both TH cells and CTLs utilize granule excytosis. As mentioned 
previously, the principal target for CTL-mediated cytolysis is the IAV-infected RECs 
(Topham et al. 1997; Hufford et al. 2011), whose elimination is essential for successful IAV 
clearance. The capacity for TH cells to engage in granule exocytosis has only been recently 
appreciated. Few RECs express MHC II (Gereke et al. 2009), and MHC II respiratory 
epithelium deficiency does not influence IAV clearance in murine models (Topham et al. 
1996b). However, passive transfer of cytotoxic TH cells into IAV-infected wild type or B 
cell-deficient mice can improve host morbidity (Brown et al. 2006; Hua et al. 2013). In 
addition, the presence of IAV-specific TH cells correlated with improved disease protection 
in patients with heterologous influenza infections (Wilkinson et al. 2012), indicating TH 
cell-mediated cytolysis may be of significant benefit during subsequent infections.
4.1.2 TNF Family Members—Cytotoxicity can be elicited by a variety of TNF family 
members, the prototypical example being FasL. Interaction of FasL with its cognate 
receptor, Fas, is vital in regulating T cell homeostasis, and human deficiencies in Fas 
signaling result in autoimmune lymphoproliferative syndrome (Roths et al. 1984; Legge and 
Braciale 2005; Stranges et al. 2007; Imai et al. 2012); however, these interactions can also 
be critical in eradicating virally infected cells, notably during IAV infections (Topham et al. 
1997; Hufford et al. 2011).
TCR engagement with peptide complexed MHC upregulates FasL expression in T 
lymphocytes. The nature of FasL trafficking to the outer membrane is debatable with 
evidence indicating FasL deposition is dependent on vesicular traffic of premade FasL 
molecules onto the outer membrane (Isaaz et al. 1995; Li et al. 1998; Lettau et al. 2006) or 
de novo transcription/translation following TCR engagement (Lowin et al. 1996). 
Nonetheless, FasL-mediated cytotoxicity occurs via the oligomerization of the target cell’s 
Fas molecules, which are expressed on the cellular membranes of most cell types, by 
membrane-bound FasL (Rouvier et al. 1993). FasL is sensitive to metalloproteinase cleavage 
on the cell surface (Kayagaki et al. 1995), thereby limiting surface exposure and minimizing 
non-specific cell killing. This soluble form of FasL is a chemoattractant and can induce 
nonspecific cell death, albeit at much less efficiency as its membrane-bound counterpart 
(Schneider et al. 1998; Ottonello et al. 1999).
Fas signaling on the target cell’s surface requires Fas trimerization, which may or may not 
precede binding to FasL (Siegel et al. 2000; Dockrell 2003). Upon FasL/Fas engagement, 
Fas-associated death domain (FADD) binds the death domain of Fas and recruits pro-
caspase-8. Caspase 8 proceeds to cleave pro-apoptotic Bid, thereby initiating the 
mitochondrial apoptotic pathway, and in parallel, converts pro-caspase-3 to caspase 3 
leading to a subsequent apoptotic caspase cascade.
Additional TNF family molecules can initiate cytotoxicity, either as soluble factors (i.e., 
TNF—as discussed later) or membrane-bound ligands (i.e., TNF-related apoptosis-inducing 
ligand (TRAIL)). TRAIL-induced apoptosis is commonly associated with tumor clearance 
(Benedict and Ware 2012); however, there is evidence of its importance in viral models 
(Lum et al. 2001; Kotelkin et al. 2003). TRAIL and its cognate ligand, TRAIL-death 
receptor (TRAIL-DR), are similar to FasL/Fas in that TRAIL engagement with TRAIL-DR 
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recruits a death complex, thereby initiating an apoptosis cascade (Benedict and Ware 2012). 
Like FasL, TRAIL also can be present in a soluble form. Nonspecific cell death may be 
limited because high TRAIL-DR expression is limited to IAV-infected cells compared to 
noninfected cells (Brincks et al. 2008; Herold et al. 2008), and TRAIL expression in CTLs is 
partially regulated by TCR stimulus (Ishikawa et al. 2005; Brincks et al. 2008). In murine 
models, neutralization of TRAIL or the use of TRAIL deficient mice leads to delayed IAV 
clearance and increased morbidity (Ishikawa et al. 2005; Brincks et al. 2008); however, the 
significant role for TRAIL in regulating CTL expansion and migration during influenza 
infection must also be taken into account (Brincks et al. 2011)
4.2 T Cell Soluble Mediators
CTLs and in particular, TH cells produce a wide array of cytokines and chemokines upon 
their infiltration into the IAV-infected lung (Fig. 2). The TCR-mediated production of these 
soluble mediators is important in ultimately orchestrating the elimination of infectious IAV 
while also minimizing the extant of the resulting inflammation. While impossible to describe 
all the T cell-derived products, the following subsections highlight pivotal cytokines/
chemokines shaping IAV disease.
4.2.1 IFNγ—IFNγ is the most prominent cytokine produced by both IAV-specific TH cells 
and CTLs upon entry into the infected lung. While other cell types can produce IFNγ, the 
peak IFNγ production coincides with the arrival of IAV-specific TH cells and CTLs into the 
respiratory tract, and acute removal of both subsets with depleting antibodies effectively 
eliminates detectable IFNγ (Hufford et al. 2011).
IFNγ can activate immune cells (e.g., macrophages), upregulate immunemodulating 
molecules (e.g., MHC), and modulate antibody isotype switching. Despite these processes, 
IFNγ deficiency has no impact on IAV clearance (Graham et al. 1993). It is likely that IFNγ 
contributes to viral clearance but is not essential due to overlapping antiviral mechanisms. 
This concept is illustrated in nitric oxide synthase knockout mice (unable to synthesize the 
inflammatory signaling molecule nitric oxide), which require IFNγ for the elimination of 
IAV (Karupiah et al. 1998). Additionally, absence of IFNγ during murine influenza 
infections has been demonstrated to affect leukocyte recruitment (Baumgarth and Kelso 
1996; Turner et al. 2007), isotype switched antibody levels (Baumgarth and Kelso 1996; Bot 
et al. 1998), and immunopathology (Wiley et al. 2001).
There is sparse evidence to suggest that IFNγ is a significant contributor to immune-
associated tissue damage during IAV infection. Rather, its absence can be linked with 
reduced tissue damage, likely due to its impact in regulating leukocyte recruitment to the 
lung (Wiley et al. 2001). However, IFNγ may contribute to the susceptibility to secondary 
bacterial infections during IAV infection. During IAV infection, alveolar macrophages 
exhibit decreased expression of the scavenger molecule MARCO (macrophage receptor with 
collagenous structure) and reduced capacity to phagocytize bacteria (Sun and Metzger 
2008). Subsequently, it was demonstrated that acute IFNγ neutralization restores MARCO 
expression and bacterial ingestion in alveolar macrophages. Furthermore, IAV-infected mice 
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receiving IFNγ neutralizing antibody demonstrated increased resistance to secondary 
bacterial infection (Sun and Metzger 2008).
4.2.2 TNF—TNF is produced by both TH cells and CTLs, usually in conjunction with IFNγ 
production. Unlike other T cell-derived effector molecules (e.g., IFNγ, granzymes) TNF 
release is nonpolarized, rather than directionally towards the stimulating target cells (Huse et 
al. 2006), potentially allowing potent nonspecific effects. In addition, many cell types can 
produce TNF upon PAMP recognition (Parameswaran and Patial 2010). It is likely that 
macrophages, rather than T cells, are the most significant source of TNF during influenza 
infection.
TNF is a pleiotropic cytokine, whose function is dependent on the manner of presentation, 
the target cell type engaged, and the local inflammatory environment (Parameswaran and 
Patial 2010). Upon stimulation, TNF can be presented in both soluble and membrane forms. 
In addition, there are two TNF receptors: (1) TNFR1, which is expressed in all cell types, 
can bind both forms of TNF and contains a death domain; and (2) TNFR2, which is 
predominantly expressed in immune cell types, only binds membrane-bound TNF and does 
not contain a death domain (Grell et al. 1995). TNF signaling can be also affected by the 
presence of metalloproteases, which can cleave the extracellular domains of TNFR1 and 
TNFR2, thereby prohibiting further TNF signaling (Van Zee et al. 1992).
Because of the overall complexity of TNF signaling, TNF may promote anti-inflammatory 
(e.g., diminish cytokine production, inhibit phagocytosis, trigger apoptosis) or pro-
inflammatory (e.g., stimulate cytokine production, augment cellular proliferation, trigger 
cellular necrosis) outcomes. A similar dichotomy in function is present during IAV 
infection. TNF has been demonstrated to reduce CCL2, a chemokine which promotes 
infiltration of inflammatory monocytes/macrophages into the lung (Damjanovic et al. 2011). 
In contrast, TNF has been demonstrated to be a significant contributor to immune-mediated 
tissue damage during IAV infection without any discernable impact on viral clearance 
(Peper and Van Campen 1995; Hussell et al. 2001; Belisle et al. 2010). It is currently 
unclear, however, whether the loss of TNF signaling in murine studies, like IFNγ, is 
compensated by other antiviral mechanisms.
4.2.3 IL-10—Potential sources of IL-10 in the lung during IAV infection are CTLs, TH 
cells, and regulatory T cells; however, IL-10 reporter mice (which effectively mark cells 
undergoing IL-10 gene expression) indicate lung CTLs are the predominant source (Sun et 
al. 2009). Despite the capacity to make IL-10, these CTLs infiltrating the respiratory tract 
are not a strict regulatory subset because they readily produce inflammatory cytokines (e.g., 
IFNγ) and are cytotoxic (Sun et al. 2009). Thus, IL-10 production is concomitant with T 
cell-mediated antiviral activity, likely to limit rather than effectively prohibit subsequent 
inflammation.
IL-10 is a potent regulatory cytokine which, upon binding to its receptor, IL-10R, on innate 
and adaptive immune cells, can downregulate MHC and co-stimulatory molecule 
expression, modulate inflammatory cytokine expression, and inhibit cellular proliferation 
(Couper et al. 2008). During IAV infection, acute blockade of IL-10R signaling during T 
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cell-mediated virus clearance results in excessive pulmonary inflammation and injury (Sun 
et al. 2009). In contract, mice with IL-10 deficiency have reduced viral titers, likely due to 
enhanced antibody production and TH cell responses (McKinstry et al. 2009; Sun et al. 
2010). Thus, the timing and location of IL-10 production can hamper antiviral immunity 
(i.e., during adaptive immune activation) or prohibit excessive pulmonary inflammation 
(i.e., during viral clearance).
4.2.4 MIP-1α—Macrophage inflammatory protein (MIP)-1α (i.e., CCL3) is readily 
produced by CTLs and TH cells upon activation (Obaru et al. 1986). Other potential sources 
include B lymphoctyes, natural killer cells, and myeloid cells (e.g., macrophages, 
neutrophils, etc.). MIP-1α is a chemokine which, upon binding to its receptors CCR1, 
CCR3, or CCR5, exerts potent chemotactic and pro-inflammatory effects (Menten et al. 
2002). MIP-1α can enhance lymphocyte cytokine production and is a potent recruiter of 
monocytes, lymphocytes, immature DCs, and activated neutrophils (Karpus et al. 1997; 
Menten et al. 2002). In IAV-infected MIP-1α deficient mice, viral clearance was delayed, 
albeit eventually achieved (Cook et al. 1995). Inefficient viral clearance was accompanied 
with deficient leukocyte recruitment in the lung and reduced tissue damage. Thus, MIP-1α is 
likely a significant pro-inflammatory soluble mediator necessary for efficient IAV clearance.
5 Regulation of Effector T cell Responses in the Lung
5.1 Local Differentiation of Effector T Cells in the Lung
As discussed previously, IAV-specific CTLs and TH cells are activated in the DLN. The 
classical view in immunology is that T cell activation and differentiation into effector T cells 
are programmed and completed in the DLN; however, recent murine studies have found that 
upon migration to the IAV-infected lungs, both IAV-specific CTLs and TH cells undergo 
extensive phenotypic changes during IAV infection, suggesting that local lung environments 
can further shape the differentiation of effector T cells (Fig. 3). CTLs activated in the DLN 
are capable of producing high levels of IFNγ upon antigenic stimulation. Interestingly, 
compared to CTLs residing in the DLN or spleen, CTLs in the lung downregulate their 
capacity to produce IFNγ following antigenic stimulation (Fulton et al. 2008), suggesting 
that lung environment factors restricts the extent of IFNγ production by CTLs to avoid 
potential collateral damage caused by exuberant IFNγ (Fulton and Varga 2010).
Coinciding with their downregulation of effector cytokine IFNγ, CTLs also acquire the 
ability to produce IL-10 upon migrating into the lung (Sun et al. 2009, 2011). It was 
demonstrated that lung CTLs, but not LN effector CTLs, produce significant amount of 
IL-10 following antigenic-stimulation in vitro (Sun et al. 2009, 2011). As discussed 
previously, IL-10 functions to inhibit exuberant pulmonary inflammation during virus-
induced diseases. Thus, these data suggested that CTLs acquire potent regulatory functions 
(i.e., capacity to produce IL-10) in the lung in response to the IAV-infected environment. 
The inflammatory cytokine IL-27 plays a critical role in the local instruction of IL-10 
production by CTLs (Sun et al. 2011). Compared to DLN, IL-27 message is highly enriched 
in the infected lungs and the cellular sources of IL-27 appear mainly to be local 
inflammatory phagocytes including DCs, macrophages, and neutrophils, which are recruited 
to the lung following IAV infection (Sun et al. 2011). Therefore, lung inflammatory 
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responses caused by virus infection are able to further instruct the continuous differentiation 
of CTLs for the acquisition of regulatory features.
TH cells also upregulate IL-10 production upon migration into the lungs, suggesting the 
same IL-27-dependent mechanisms relates to lung TH cells as well (Sun et al. 2009). More 
strikingly, TH cells in the lungs also acquire the ability to eliminate IAV-infected MHC II+ 
cells via granule exocytosis (Brown et al. 2006, 2012; Hua et al. 2013). TH cells in the DLN, 
however, express minimum granzyme B and perforin (Brown et al. 2012; Hua et al. 2013), 
suggesting that the acquisition of cytotoxic molecules in TH cells requires signals from the 
local lung environments during IAV infection. Type I IFN (expressed at higher levels in the 
IAV infected lung compared to the DLN) and IL-2 are required for the expression of 
cytotoxic molecules in lung TH cells (Hua et al. 2013). Thus, lung environmental cues 
modulate the in situ differentiation of TH cells into cytotoxic TH cells through type I IFNs.
5.2 Local Regulation of Proliferation and Survival of Effector T Cells
Besides shaping the phenotype of TH cells and CTLs, local APCs and the lung environment 
also provide essential survival and proliferation signals for lung TH cells and CTLs. Early 
studies have identified that CTLs undergo extensive proliferation in the lung following IAV 
infection (Lawrence and Braciale 2004; McGill and Legge 2009). Interestingly, acute 
depletion of mononuclear phagocytes (mostly DCs) in the lung following T cell priming 
abrogated CTL proliferation and impaired antiviral T cell responses (McGill et al. 2008), 
suggesting that local DC and T cell interaction provides signals for the continuous 
proliferation of effector T cells in the lung during influenza infection. Interestingly, like the 
proliferation of T cells during naïve T cell activation, the in situ proliferation of lung CTLs 
also requires both signal 1 (MHC-peptide stimulation) and signal 2 (B7-CD28 and CD70-
CD27 co-stimulation) during IAV infection (Dolfi et al. 2011; van Gisbergen et al. 2011). In 
addition to providing signals licensing the in situ proliferation of effector T cells, RDCs also 
provide critical surviving signals for CTLs. Mechanistically, the trans-presentation of IL-15 
by RDCs plays a critical role in sustaining the viability of lung antiviral CTLs (McGill et al. 
2010). Interestingly, IL-15 trans-presentation to effector T cells is regulated by TSLP 
signaling in DCs (Yadava et al. 2013). Taken together, these recent data have extended our 
conventional lymphoid organ-centered view of T cell responses during infection and 
established that local environmental cues can continuously shape tissue effector T cells 
phenotype and constantly modulate their function.
5.3 Molecular Mechanisms Regulating Effector T Cell Responses in the Lung
5.3.1 Transcriptional Control of Effector TH Cell Responses in the Lung—T cell 
activation and effector differentiation are subject to intensive transcriptional control, and 
various transcription factors have been demonstrated to regulate the transition from naïve T 
cells to effector T cells (O’Shea and Paul 2010; Zhang and Bevan 2011). Emerging evidence 
also suggests various transcription factors regulate the extensive phenotypic changes 
effector T cells exhibit upon their migration into the lung, as well.
B lymphocyte–induced maturation protein-1 (Blimp-1) is a transcription repressor that plays 
an important role in regulating T and B cell function (Crotty et al. 2010). The expression of 
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Blimp-1 has previously been shown to promote effector T cell migration to the lung and 
modulate memory T cell generation during IAV infection (Kallies et al. 2009). Interestingly, 
Blimp-1 is highly expressed in lung TH cells, compared to their counterparts in the DLN 
(Hua et al. 2013). Importantly, Blimp-1, whose expression can be orchestrated by IL-2 and 
type I IFN, is required for the expression of granzyme B and perforin in lung TH cells as 
well as their ability to kill target cells (Hua et al. 2013).
Besides Blimp-1, the T-box transcription factor, T-bet, also plays an important role in the 
development of lung cytotoxic TH cells during IAV infection (Hua et al. 2013). Like 
Blimp-1, T-bet expression is upregulated in lung TH cells by local type I IFN signaling (Hua 
et al. 2013). Mechanistically, T-bet and Blimp-1 cooperate to regulate the differentiation of 
cytotoxic TH cells as T-bet directly binds to cytotoxic molecules and Blimp-1 controls the 
accessibility of the cytotoxic molecule loci to T-bet (Hua et al. 2013). Thus, local cytokine 
milieu controls the development of cytotoxic TH cell development through the upregulation 
of the transcription factors T-bet and Blimp-1 during IAV infection.
5.3.2 Transcriptional Control of CTL Responses in the Lung—Besides regulating 
local TH cell differentiation, Blimp-1 also modulates local CTL responses in the lung during 
IAV infection. Similar to its function in TH cells, Blimp-1 promotes cytotoxic molecule 
expression in lung CTLs (Shin et al. 2009; Sun et al. 2011). Moreover, the production of 
IL-10 by lung CTLs is critically dependent on Blimp-1 during IAV infection. The ablation 
of Blimp-1 expression in CTLs specifically abrogate IL-10 but not IFNγ production by 
CTLs following antigen restimulation (Sun et al. 2011), suggesting that Blimp-1 is uniquely 
required for the requisition of regulatory function of effector CTLs. Consistent with this 
result, T cell specific Blimp-1 deficiency is associated with enhanced host inflammation in 
the airway (Sun et al. 2011). Notably, IL-27, which is highly produced in the lung compared 
to the DLN, cooperates with IL-2 to induce Blimp-1 expression in CTLs (Sun et al. 2011). 
Thus, Blimp-1 appears to be a transcription factor that translates local environmental cues 
into the phenotypic and functional traits of lung effector TH cell and CTLs during IAV 
infection. Recently, interferon-regulatory factor (IRF) 4 was shown to play an essential role 
in regulating both the quality and quantity of CTL responses during IAV infection (Man et 
al. 2013; Yao et al. 2013). IRF4 acts as a transcriptional activator to promote effector 
differentiation and as a transcriptional repressor to regulate cell cycle progression and 
survival, thereby sustaining both the expansion and effector differentiation of CTLs during 
IAV infection (Yao et al. 2013). Interestingly, the conditional deletion of IRF4 expression in 
CD8+ T cells specifically impairs the proliferation and survival of lung CTLs (Yao et al. 
2013), suggesting that IRF4 is a critical regulator of CTL responses in the lung in vivo. As 
discussed previously, RDCs can sustain CTL proliferation and survival through the 
provision of antigen, co-stimulatory molecules, and cytokines. Thus, it is tempting to 
speculate that local DCs exert their function by promoting IRF4 expression in lung CTLs.
5.4 In Situ Control of Effector T Cell Activities by Different Types of APCs
Effector T cells express high levels of mRNAs encoding various effector cytokines and 
cytotoxic molecules and thus are able to promptly produce these cytokines and cytotoxic 
molecules following antigenic or mitogenic stimulation. However, it is important to note 
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that effector T cells do not spontaneously secret cytokines or release cytotoxic molecules in 
vivo without further stimulation due to additional layers of translational control of cytokine 
expression, possibly to avoid potential self-destruction. Classically, the activities of effector 
T cells (i.e., production of cytokines and release of cytotoxic molecules) were often 
monitored through in vitro cytokine staining and degranulation assays following maximally 
antigenic or mitogenic stimulation. Such methods are efficient to measure the potential of 
effector T cells to produce cytokines and release cytotoxic molecules but fail to faithfully 
report the in vivo activities of effector T cells. In an in vivo setting, effector T cells likely 
interact with multiple target cell types and the strength of antigenic stimulation they receive 
from these cells could vary drastically. In particular, as noted above, early in vitro analysis 
demonstrated an expressional hierarchy in the regulation of T cell effector activities in 
which high-strength antigenic signaling induces the production of cytokine and release of 
cytotoxic molecules, while weak antigenic stimulation only induces the release of cytotoxic 
molecules but not the production of cytokines (Valitutti et al. 1996).
During IAV infection, the infected lungs contain many cell types that potentially bear IAV 
antigen (Kohlmeier and Woodland 2009; Braciale et al. 2012). These cells include both 
infiltrating lung CD45+ APCs as well as CD45− RECs. Interestingly, it was recently 
demonstrated that the interaction of CTLs with RECs and APCs resulted in differential 
effector activities by CTLs (Hufford et al. 2011). Using techniques that measure the in vivo 
release of cytokines through the injection of a reagent inhibiting T cell secretion, Hufford et 
al found that effector T cells releasing IFNγ primarily reside in the lung interstitium rather 
than the airways (Hufford et al. 2011). Since the lung interstitium is enriched with APCs, the 
authors further demonstrated that the interaction of the APCs with effector CTLs triggers the 
release of both cytokines and cytotoxic molecules, while the interaction of RECs with CTLs 
primarily induce the release of cytotoxic molecules but not effector cytokines by CTLs 
(Hufford et al. 2011). One crucial difference between the APC and CD45− target is the 
expression of the co-stimulatory ligands, B7-1 and B7-2. Lung APCs express high levels of 
B7 molecules (which ligate CD28 in the effector CTLs) while RECs express minimal B7 
expression (Hufford et al. 2011). Indeed, blockade of the B7-CD28 interaction suppresses 
IFNγ production by effector CD8 T cells but not their cytotoxic activity or virus clearance in 
vivo. Thus, the engagement of co-stimulatory receptors on effector CD8+ T cells by APCs 
provide the additional signal strength necessary for the production of pro-inflammatory 
cytokines by the T cells (Hufford et al. 2011). In further analysis, the principal population 
stimulating in vivo release of effector cytokines by CTLs were the lung CD11c+ 
inflammatory DCs or TipDCs (Aldridge et al. 2009; Neyt and Lambrecht 2013). The acute 
depletion of CD11c+ cells in the lung drastically abrogate in vivo effector T cell cytokine 
production (Hufford et al. 2011). Thus, lung DCs controls all the aspects of CTL responses 
in the lungs including survival, proliferation, differentiation, and effector activities.
Surprisingly, another significant population of lung APCs was neutrophils. Neutrophils were 
previously demonstrated to be required for the innate defense against IAV infection. Despite 
their condensed nuclei and low levels of gene transcription, neutrophils can be directly 
infected with IAV transcribe viral genes, and thus contain significant influenza antigen. In 
vivo depletion of neutrophils diminished CTL IFNγ production (Hufford et al. 2012). These 
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data demonstrated that neutrophils are required for triggering the maximal effector activities 
of CTLs in vivo.
The aforementioned results have revealed a potential new layer of effector T cell regulation 
in vivo: effector T cell activities in the lung are differentially regulated by the strength of 
interaction with their target cell types. This uncoupling of the release of inflammatory 
cytokines and the release of cytolytic molecules by effector T cells may be employed in the 
future to design novel therapeutics for influenza infection (Sun and Braciale 2013). For 
example, the specific blockade of certain co-stimulatory signals such as B7 may specifically 
dampen unwanted tissue inflammation by inhibiting the release of pathogenic cytokines 
from effector T cells but not perturb viral clearance since this blockade regimen specifically 
retain the ability of effector T cells to clear virus through cytotoxic molecule-dependent 
mechanisms.
6 Conclusion and Future Avenues of Research
This report has reviewed the current state of knowledge concerning the effector T cell 
response to IAV infection in the experimental setting. As the findings within demonstrated, 
our knowledge of the factors regulating the induction of adaptive immune T cell responses 
to IAV, the effector activities displayed by these activated T cells, the mechanisms 
underlying the expression of these effector mechanisms, and the control of the activation/
differentiation state of these T cells in the infected lungs has progressed dramatically in 
recent years. While of necessity much of this information has come from studies in 
experimental nonhuman IAV infections, this work has provided both insight and a focus for 
current and future research in human IAV infection (Lee et al. 2011).
Although we now understand the broad outline of the events regulating the response of 
CD8+ and CD4+ T cells to respiratory virus infections like IAV, there remains both larger 
fundamental issues concerning the course of the host response during and following virus 
clearance as well as specific questions related to the role of specific cell types within the 
uninfected and infected respiratory tract as inducers and regulators of T effector cell activity 
and as targets for immune recognition. A major gap in our knowledge is the process of 
restoration of normal pulmonary function following a severe the respiratory tract IAV 
infection and the contribution (if any) from effector T cells remaining in the lungs following 
infectious virus clearance. Likewise, the role of specific cell types such as the alveolar 
macrophages and distinct subsets of RDC both as inducers of effector T cell differentiation 
and as targets and regulators of T cell effector activity need to be understood. Equally 
importantly is the need for a deeper understanding, in particular in the human, of the impact 
of differential susceptibility of various cell types in the respiratory tract to infection by 
different IAV strains (i.e., both seasonal and pandemic) on disease severity and the outcome 
of infection. As we look to the prospect of a “universal influenza vaccine,” we must also be 
cognizant of the need to develop novel strategies to control excess inflammation in those 
individuals unfortunate enough to develop severe life-threatening IAV infection.
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APC Antigen presenting cell
Bid BH3 interacting-domain death agonist
Blimp-1 B lymphocyte–induced maturation protein-1
cRDC Conventional RDC
CTL Cytotoxic T lymphocyte
DAMP Damage-associated molecular pattern
DC Dendritic cell
DLN Draining lymph node
FADD Fas-associated death domain (FADD)
FasL Fas ligand
IAV Influenza A virus
IFN Interferon
IL Interleukin
IRF IFN Regulatory factor
MIP-1α Macrophage inflammatory protein-1α
MARCO Macrophage receptor with collagenous structure
MAVS Mitochondrial antiviral signaling
MHC Major histocompatibility complex
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NLR NOD-like receptor
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RDC Respiratory DC
REC Respiratory epithelial cell
RIG-I Retnoic acid-inducible gene 1
RLR Rig-I-like receptor
TCR T cell receptor
TH T helper
TipDC TNF+iNOS+ DC
TLR Toll-like receptor
TNF Tumor necrosis factor
TRAIL TNF-related apoptosis-inducing ligand
TRAIL-DR TRAIL-death receptor
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Fig. 1. 
Effector T cell-mediated cytotoxic pathways during influenza infection: (1) Granuale 
excytosis is initiated following TCR stimulus resulting in the release of premade cytotoxic 
granuales onto target cells. The subsequent release of the pore-forming protein perforin and 
serine proteases (granzymes) activate caspase cascades resulting in target cell apoptosis. (2) 
TNF-related proteins are upregulated upon TCR stimulus. Binding to their respective 
ligands on target cells recruits ligand associated death domains which ultimately activate 
caspase cascades resulting in target cell apoptosis
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Fig. 2. 
The major types and functions of soluble mediators produced by effector T cells during IAV 
infection. Upon entry into the lung and subsequent TCR stimulation, IAV-specific T cells 
can produce an array of cytokines and chemokines. Major T cell derived soluble factors 
involved in influenza disease are depicted along with a brief summary of function
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Fig. 3. 
Lung APCs shape local CTL and CD4+ TH cell responses by providing essential 
differentiation, survival, and proliferation signals. Within the DLN, professional APCs and 
local inflammatory milieu control the early stages of antigen-specific T cell proliferation and 
differentiation. During influenza infection, there is significant evidence demonstrating that 
upon arrival into the infected lung after activation in the DLN, effector T cells undergo 
additional rounds of differentiation and proliferation regulated by APCs present in the 
respiratory tract and locally produced soluble mediators
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